北京商报讯（记者 丁宁）1月9日晚间，富祥药业（300497）发布公告称，公司拟与上海凌凯科技股份 有限公司（以下简称"上海凌凯"）签署《股权转让协议》，将持有的上海凌富药物研究有限公司（以下 简称"上海凌富"）39.2%股权（对应公司注册资本3920万元）以4277万元的价格转让给上海凌凯，本次 交易完成后，公司将不再持有上海凌富股权。 富祥药业表示，本次交易是公司根据对外投资的具体进展，结合公司未来战略发展规划和经营情况，经 审慎研究后做出的合理决策。此举旨在通过股权转让实现资金回笼、降低投资风险，集中资源巩固与提 升主业核心竞争力。同时，公司期望通过优化投资结构，进一步增强资产流动性和整体抗风险能力，从 而保障公司长期可持续发展，切实维护公司及全体股东特别是中小股东的合法权益。 ...

智通财经APP讯，富祥药业(300497.SZ)公告，公司拟与上海凌凯科技股份有限公司("上海凌凯")签署 《股权转让协议》，将持有的上海凌富药物研究有限公司("上海凌富")39.20%股权以4277万元的价格转 让给上海凌凯，本次交易完成后，公司将不再持有上海凌富股权。此举旨在通过股权转让实现资金回 笼、降低投资风险，集中资源巩固与提升主业核心竞争力。同时，公司期望通过优化投资结构，进一步 增强资产流动性和整体抗风险能力。 ...

智通财经APP讯，富祥药业(300497.SZ)公告，公司拟与上海凌凯科技股份有限公司("上海凌凯")签署 《股权转让协议》，将持有的上海凌富药物研究有限公司("上海凌富")39.20%股权以4277万元的价格转 让给上海凌凯，本次交易完成后，公司将不再持有上海凌富股权。此举旨在通过股权转让实现资金回 笼、降低投资风险，集中资源巩固与提升主业核心竞争力。同时，公司期望通过优化投资结构，进一步 增强资产流动性和整体抗风险能力。 ...

中央经济工作会议12月10日至11日在北京举行。会议提出，坚持内需主导，建设强大国内市场。 复旦大学管理学院科创中心首席经济学家邵宇表示，为有效拉动内需，关键是通过强化社会保障以 提升居民消费信心，并稳定财产价值以保障消费能力，同时优化投资结构，聚焦重大工程和民生项目以 增强长期增长动力。 演播室：白阳 刘倩朋 朱文喆 施悦炜 武坤辉 王小晴 联合拍摄：新华社上海分社 上海市徐汇区融媒体中心 新华社音视频部制作 【纠错】 【责任编辑:赵文涵】 统筹：姚玉洁 汪奇文 编导：李海伟 王竹艾 记者：有之炘 潘清 ...

Core Viewpoint - Oriental Pearl (600637.SH) has announced a partnership to establish a new investment fund, aiming to enhance asset value through strategic investments in Xinhua San [1] Group 1: Investment Details - The company signed a partnership agreement with Hefei Huaxin Shiheng Enterprise Management Consulting Partnership (Limited Partnership) and five other firms to set up the Hefei Huaxin Mingzhu Equity Investment Partnership (Limited Partnership) [1] - The total fund size is set at 1 billion yuan, with the company committing to contribute 499.9 million yuan, representing approximately 49.99% of the total fundraising [1] Group 2: Strategic Objectives - The partnership aims to invest in Xinhua San through equity investments to achieve asset appreciation [1] - This investment is expected to leverage the strengths of all parties involved, utilizing a professional investment management team to optimize the company's investment structure and enhance investment returns and asset operation capabilities [1]

Core Viewpoint - The Fourth Plenary Session of the 20th Central Committee of the Communist Party of China outlined the "15th Five-Year Plan" for economic and social development, emphasizing the importance of achieving socialist modernization by 2035, with a key indicator being per capita GDP reaching the level of moderately developed countries [1] Economic Growth and Productivity - The "15th Five-Year Plan" aims for economic growth to remain within a reasonable range, with steady improvements in total factor productivity and synchronized growth of residents' income and economic growth [1] - The potential economic growth rate for China is estimated to be around 4.7% from 2026 to 2030, with contributions from capital formation at 2.7 percentage points and total factor productivity at 2.0 percentage points [8] - To achieve the goal of per capita GDP reaching the level of moderately developed countries by 2035, an annual GDP growth rate of approximately 4.7% is required during the "15th Five-Year Plan" period [8] Macroeconomic Policies - The plan emphasizes the need for proactive macroeconomic policies, including active fiscal policies and moderately loose monetary policies, to stabilize growth, employment, and expectations [9] - Fiscal spending should outpace nominal economic growth, focusing on improving the efficiency of fund usage and ensuring social welfare [9] - Monetary policy should ensure real interest rates decline and maintain ample liquidity, with structural monetary tools supporting key sectors [10] Domestic Demand and Consumption - The "15th Five-Year Plan" stresses the importance of expanding domestic demand and enhancing consumption as a key driver of economic growth [11] - To boost consumption, it is essential to address issues related to consumer confidence, capability, and willingness, including improving social security and income distribution [12] - Significant investment opportunities exist in public services and infrastructure, particularly in sectors like technology, education, and healthcare, which can create more consumption scenarios [13] Industrial and Technological Development - The plan prioritizes the construction of a modern industrial system and high-level technological self-reliance, focusing on enhancing the integrity, advancement, and security of the industrial system [16] - Emphasis is placed on promoting innovation through improved support for research and development, enhancing the collaboration between industry and academia, and optimizing the allocation of resources [15][16] - The need to address "involution" in competition, characterized by price wars and cost-cutting measures, is highlighted, with calls for regulatory improvements and market mechanism enhancements [14][15]

Group 1 - The company plans to invest $70 million through its wholly-owned subsidiary, Inco Medical International Co., Ltd., in the Warburg Pincus Global Growth 15, L.P. fund [1][2] - The target fundraising size for the partnership is $17 billion [1][2] - This transaction is classified as a related party transaction but does not exceed 5% of the company's most recent audited net assets, thus it does not require shareholder approval [1][2] Group 2 - The investment aims to optimize the investment structure and enhance the global strategic layout of the company [1][2] - The company intends to leverage a specialized investment management team to improve its revenue levels and promote long-term strategic development [1][2]

Core Viewpoint - In order to optimize its investment structure and enhance its global strategic layout, the company has decided to invest in Warburg Pincus Global Growth 15, L.P. through its wholly-owned subsidiary, aiming to improve its revenue levels and long-term strategic development [1] Group 1 - The company held its 11th meeting of the 4th Board of Directors on October 20, 2025, where it approved the proposal to invest in Warburg Pincus Global Growth 15, L.P. [1] - The investment will be made by the company's subsidiary, Inco Medical International (Hong Kong) Limited, which will sign a subscription agreement to invest in the fund [1] - The target fundraising size of the partnership is set at $1.7 billion, with the company committing to contribute $70 million as a limited partner [1]

Core Viewpoint - The company plans to invest $70 million in the Warburg Pincus Global Growth 15, L.P. partnership, which aims to raise a total of $17 billion [1] Group 1: Investment Details - The investment will be made by the company's wholly-owned subsidiary, Yingke Medical International (Hong Kong) Limited [1] - The transaction is classified as a related party transaction but does not exceed 5% of the company's latest audited net assets, thus not requiring shareholder approval [1] Group 2: Strategic Objectives - The investment aims to optimize the company's investment structure and enhance its global strategic layout [1] - The company seeks to leverage a specialized investment management team to improve its revenue levels and long-term strategic development [1]

Core Points - Xiamen Port Development Co., Ltd. held its 15th meeting of the 8th Board of Directors on September 26, 2025, and approved the proposal for the liquidation and cancellation of its holding subsidiary, Port Materials [1] - The registered capital of Port Materials was 50 million yuan, with shareholding ratios of 51%, 24.5%, and 24.5% held by Xiamen Road and Bridge Materials Co., Ltd., Heyuan Cheng (Xiamen) Supply Chain Management Co., Ltd., and Dingxin Chang (Xiamen) Industrial Co., Ltd. respectively [1] - Due to a prolonged downturn in the construction materials industry and a continuous decline in ready-mixed concrete prices since 2021, Port Materials faced operational challenges and failed to meet expected performance [1] - The Board of Directors of Xiamen Port made a prudent decision to liquidate Port Materials, which is within the approval authority of the Board and does not require shareholder meeting approval, nor does it involve related transactions or constitute a major asset restructuring [1] - The business scale, revenue, and profit of Port Materials are relatively small compared to Xiamen Port, and the liquidation is expected to optimize the external investment projects and structure of Xiamen Port and Port Trade, improving capital efficiency without significantly impacting overall operations or harming the interests of shareholders, especially minority shareholders [1] - The voting result for the proposal was 9 votes in favor, 0 against, and 0 abstentions [1]